Effects of Korodin? Herz-Kreislauf-Tropfen on low blood pressure and cognitive functions in adolescents

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2012-005810-21-DE

Enrollment

100

Registered

2014-03-24

Start date

2014-04-16

Completion date

Unknown

Last updated

2014-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: Korodin® Herz-Kreislauf-Tropfen Pharmaceutical Form: Oral drops, liquid INN or Proposed INN: D-Camphor Other descriptive name: D-CAMPHOR Concentration unit: g gram(s) Concentration number

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: 100 F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Germany

Contacts

Public ContactRobugen GmbH

Robugen GmbH

mauzm@robugen.de004971113630111

Outcome results